| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.56B | 164.60B | 150.91B | 134.27B | 130.13B | 118.38B |
| Gross Profit | 83.08B | 84.40B | 77.31B | 69.46B | 67.18B | 59.09B |
| EBITDA | 10.84B | 12.81B | 9.64B | 9.21B | 8.43B | 3.64B |
| Net Income | 5.92B | 6.11B | 4.28B | 4.88B | 4.34B | 732.00M |
Balance Sheet | ||||||
| Total Assets | 79.16B | 71.51B | 70.55B | 60.42B | 61.18B | 59.70B |
| Cash, Cash Equivalents and Short-Term Investments | 6.27B | 3.46B | 6.67B | 6.49B | 8.56B | 5.59B |
| Total Debt | 8.20B | 1.90B | 1.03B | 202.00M | 2.50B | 7.80B |
| Total Liabilities | 36.50B | 29.37B | 32.73B | 25.39B | 27.48B | 29.63B |
| Stockholders Equity | 42.66B | 42.13B | 37.82B | 35.03B | 33.70B | 30.07B |
Cash Flow | ||||||
| Free Cash Flow | -2.55B | 13.00M | 4.46B | 3.26B | 9.10B | 5.96B |
| Operating Cash Flow | 3.42B | 5.55B | 7.10B | 6.34B | 10.26B | 6.89B |
| Investing Cash Flow | -7.39B | -9.63B | -6.24B | -2.66B | -1.25B | 215.00M |
| Financing Cash Flow | 3.32B | 842.00M | -699.00M | -5.77B | -5.98B | -8.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥22.70T | 40.16 | 19.84% | 0.90% | 11.25% | 16.84% | |
73 Outperform | ¥70.21B | 10.90 | ― | 2.73% | 9.07% | 42.66% | |
73 Outperform | ¥691.84B | 20.92 | 8.48% | 2.02% | 5.20% | 6.54% | |
71 Outperform | ¥116.27B | 24.22 | 5.53% | 6.09% | -1.90% | -9.34% | |
71 Outperform | ¥265.89B | 19.34 | ― | 1.46% | 12.93% | 32.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
50 Neutral | ¥26.04B | -50.53 | ― | 4.99% | -11.48% | ― |